|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Mylan Laboratories Inc.
|
| Published Date:
October 2009
Published By:
SGA Lists
Page Count:
4
Order Code:
R406-18060
|
|
| Mylan Inc. is one of the world`s leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry`s broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey, L.P., Mylan`s fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.
|
Similar Products
• United States Type 2 Diabetes Market
Published Nov 2009 by Intellent
• Argentina Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Thailand Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Kenya Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Australia Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Company Financials: Bayer AG
Published Nov 2009 by Datamonitor
• Poland Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Takeda Pipeline, Products, Performance, Potential
Published Nov 2009 by Espicom Healthcare Intelligence
• Merck & Co. Performance, Products, Pipeline and Potential
Published Nov 2009 by Espicom Healthcare Intelligence
• Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
|
|
|
|
0 items
